Cargando…
Proton Beam Therapy for Non-Small Cell Lung Cancer: Current Clinical Evidence and Future Directions
Lung cancer is the leading cancer cause of death in the United States. Radiotherapy is an essential component of the definitive treatment of early-stage and locally-advanced lung cancer, and the palliative treatment of metastatic lung cancer. Proton beam therapy (PBT), through its characteristic Bra...
Autores principales: | Berman, Abigail T., St. James, Sara, Rengan, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586764/ https://www.ncbi.nlm.nih.gov/pubmed/26147335 http://dx.doi.org/10.3390/cancers7030831 |
Ejemplares similares
-
An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer
por: Berman, Abigail T, et al.
Publicado: (2013) -
Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard, Patrick J, et al.
Publicado: (2016) -
EGFR inhibition in non-small cell lung cancer: current evidence and future directions
por: Chi, Alexander, et al.
Publicado: (2013) -
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry
por: Jongen, Aurélien, et al.
Publicado: (2021) -
Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)